Guidelines for performing skin tests withdrugs in the investigation of cutaneous adverse drug reactions

@article{Barbaud2001GuidelinesFP,
  title={Guidelines for performing skin tests withdrugs in the investigation of cutaneous adverse drug reactions},
  author={Annick Barbaud and Margarida Gonçalo and D P Bruynzeel and A J Bircher},
  journal={Contact Dermatitis},
  year={2001},
  volume={45}
}
Skin testing with a suspected drug has been reported to be helpful in determining the cause of cutaneous adverse drug reactions (CADR). Many isolated reports of positive drug skin tests are published, but without detailed information concerning the clinical features of the CADR and the method used in performing drug skin tests, such data are not very informative. A working party of the European Society of Contact Dermatitis (ESCD) for the study of skin testing in investigating cutaneous adverse… 
Stamping a Case of Cutaneous Adverse Drug Reaction: Proving Beyond Causality Assessment
TLDR
Drug skin tests are performed 6 weeks to 6 months after complete healing of the CADR and are similar to the methods used in patch testing in studying contact dermatitis.
Drug patch testing in systemic cutaneous drug allergy.
TLDR
It is advised to perform drug patch tests during the 6 months following the CADR as the authors do not know whether positive results will persist and it is always necessary to consider the relevance of any positive drug patch test.
Drug skin tests and systemic cutaneous adverse drug reactions: an update
TLDR
The analysis of recent literature permits to propose which tests to choose for each clinical feature of CADR and to give the lis...
Usefulness of drug patch testing in cutaneous drug allergy: what is new?
Abstract Recent studies have emphasized the value of drug patch tests, in addition to, prick and intradermal tests to determine the molecule responsible for cutaneous adverse drug reactions (CADR),
Usefulness of Cutaneous Provocation Tests to Study Drugs Responsible for Cutaneous Adverse Drug Reactions
  • M. Gonçalo
  • Medicine
    Current Treatment Options in Allergy
  • 2019
TLDR
Patch tests are safe and highly specific when performed according to the recommendations, but sensitivity is highest in exanthemas, DRESS, and fixed drug eruptions and particularly for abacavir, carbamazepine, aminopenicillins and other antibiotics, diltiazem, and tetrazepam.
Skin testing in delayed reactions to drugs.
  • A. Barbaud
  • Medicine
    Immunology and allergy clinics of North America
  • 2009
TLDR
Details of the use of patch tests as they apply to patients with various drug reactions are discussed, useful to study cross-reactivity between suspected drugs.
Testing Procedures in Cutaneous Systemic Adverse Drug Reactions
TLDR
A careful analysis of criteria has led French authors to describe a scale of imputation (or imputability), which includes intrinsic and extrinsic factors and is highly recommended when CADRs to new drugs are reported.
Diagnosis of Allergic Reactions to Drugs
TLDR
In diagnosing drug allergies, history, skin testing, some in vitro laboratory tests and the challenge test are the backbone of the investigation and receiver-operating characteristic (ROC) curves provide more information to aid discrimination between positive and negative results.
Patch testing in adverse drug reactions
Cutaneous adverse drug reactions (CADRs), defined as skin eruptions induced by drugs used in adequate doses and in the correct indications, present under different clinical patterns, and the
Allergological approach to drug hypersensitivity reactions
  • B. Przybilla, W. Aberer, +14 authors H. Merk
  • Medicine
    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
  • 2008
TLDR
Drug hypersensitivity reactions have to be tested to identify the culprit substance by performing skin prick test, intradermal test, patch test or photopatch test, if the culprit drug cannot be identified by the above mentioned tests.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 76 REFERENCES
The use of skin testing in the investigation of cutaneous adverse drug reactions
TLDR
The value of careful sequential drug skin testing in establishing the cause of cutaneous ADR is supported, as a significantly higher number of positive patch tests was observed in maculopapular rashes than in urticarial reactions.
Relevance of skin tests with drugs in investigating cutaneous adverse drug reactions
Skin tests with drugs can be of value in investigating patients who have developed cutaneous adverse drug reactions (CADR), but their specificity and relevance remain to be determined. A
Patch testing in severe cutaneous adverse drug reactions, including Stevens‐Johnson syndrome and toxic epidermal necrolysis
TLDR
The results suggest that patch testing has a weak sensitivity in SJS'TEN and is not appropriate in these diseases, and patch testing seems more adapted to other cutaneous ADRs, such as AC it: P. in which the proportion of positive patch tests was significantly higher (P<0.02).
Patch testing in cutaneous reactions caused by carbamazepine
TLDR
The present study suggests that patch testing is useful in the diagnosis of carbamazepine allergy in patients with maculopapular eruptions or erythrodermas.
Evaluation of Skin Test Reactions in Patients with Non‐immediate Type Drug Eruptions
TLDR
It is considered that the combination of patch testing and intradermal testing is useful for determination of causative drugs in delayed type drug eruptions.
Natural evolution of skin test sensitivity in patients allergic to beta-lactam antibiotics.
TLDR
Patients with a selective response to amoxicillin tended to lose sensitivity faster than those who responded to several penicillin determinants, supporting the existence of at least 2 distinct types of IgE response in patients allergic to beta-lactam.
Patch testing with carbamazepine: reinduction of an exfoliative dermatitis.
TLDR
A 16-year-old girl who had a history of epilepsy and depressive personality disorder was admitted to the hospital with a generalized erythematous dermatitis and the initial daily dose of carbamazepine was 100mg/d, and it was increased to 300 mg/d after 20 days.
A diagnostic protocol for evaluating nonimmediate reactions to aminopenicillins.
TLDR
Both patch and intradermal tests are useful in evaluating nonimmediate reactions to APs and Intradermal testing appears to be more sensitive than patch testing, but the pattern of positive delayed intrader mal test responses and negative patch test responses needs further investigation because of false-positive cases.
Patch test diagnosis of exfoliative dermatitis due to carbamazepine
TLDR
A 32-year-old man who worked in a pharmaceutical company, who suffered from frequent seizures and loss of consciousness since August, 1983, was diagnosed with epilepsy by means of EEG and patch testing may be useful in the diagnosis of drug reactions.
Fixed drug eruption to piroxicam. Positive patch tests with cross-sensitivity to tenoxicam
TLDR
Patch testing on lesional skin revealed cross-sensitivity between piroxicam and tenoxicam, but no reactivity to thiosalicylic acid, which suggests that the molecular moiety involved in FDE to piroXicam is shared by ten toxicam, in contrast to pIROxicams photosensitivity where there is no cross-reaction between these two drugs.
...
1
2
3
4
5
...